Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

“Commonly known as the stomach flu, norovirus has been around forever, and has become the leading cause of gastroenteritis or inflammation of the intestinal tract that causes vomiting and diarrhea,” ...

Importantly, they can be personalised to encode specific antigens, do not run the ... only anti-COVID-19 mRNA vaccines have received regulatory approval, and further work is needed to optimise ...

But we can’t do it on our own ... Here’s how it would work: A nasal mRNA vaccine would be taken as a spray through the nose, coating the nasal passages. The cells in the nasal lining would ...

The mRNA vaccines generate an immune response and give the body’s cells a blueprint to help it later do battle with an ...

The latest guidance reduction was the second time in the last six months that the firm has revised its forecast in a negative ...

Russia's announcement of a personalised mRNA cancer vaccine has generated excitement, but experts urge caution. While mRNA technology shows potential, the lack of clinical data and the gap between ...

The mRNA-1273.815 vaccine provided significant protection against COVID-19-related hospitalizations and medically attended COVID-19 among US adults.

Moderna's mRNA technology gained rapid validation ... individuals in developed markets continue to get annual vaccines, although we do not assume regular vaccination for healthy adults, leading ...

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

Afrigen Biologics has secured a $6.2m grant from CEPI to develop the first mRNA-based vaccine against Rift Valley fever.